Regeneron Pharmaceuticals (REGN)

Operating Cash Flow Growth

-49.80%

Quarterly · Period ending:

REGN logo

REGN Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-49.80%
REGN Quarterly Cash from Operations YoY % (-40.74% → -49.80%)
High-resolution chart · PNG

REGN operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
-49.799%
3.2341%
-7.2933%
25.364%
223.2768%
-30.9025%
15.8851%
15.8754%
-65.3756%
10.5952%
-36.6417%
77.1824%
81.1481%
-34.9289%
-27.5068%
-81.5766%
-9.941%
214.3904%
92.7295%
1,442.3516%
-33.5701%
-4.2264%
56.3373%
-145.6307%
401.009%
-22.1851%
8.0406%
23.0514%
-52.2808%
44.958%
28.5504%
9.1767%
1,390.808%
73.8686%
50.0314%
-36.2806%
-107.6521%
691.0845%
34.0838%
-27.0844%
54.9461%
144.2252%
42.2092%
443.359%
-23.3586%
-290.048%
-28.4001%
77.7308%
162.4856%
-37.9383%
197.0231%
3,981.4022%
263.5225%
199.0889%
285.1959%
94.9032%
-130.1821%
-722.6938%
-20.6672%
-129.0878%
-169.703%
-5.7894%
10.1392%
1,735.8074%
-117.4849%
1.9414%
-29.4754%
76.3587%
-193.6744%
43.0128%
-170.5276%
-288.2804%
276.7037%
-93.7324%
-4.6639%
27.8538%
83.0375%
-275.0284%
368.5696%
1.1135%
27.6668%
-84.0698%
-62.6937%
-318.2376%
-263.7244%
278.3016%
57.0896%
-105.8017%
142.887%
-1,657.5859%
8.3704%
359.118%
-37.5748%
104.579%
-75.7449%
-8.9672%
-215.515%
-210.2775%
-368.2759%
-420.7184%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.